Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Am J Hematol. 2013 Nov 20;89(1):68–73. doi: 10.1002/ajh.23590

Figure 2. MP-associated procoagulant activity.

Figure 2

The STA-Procoag-PPL assay was used to evaluate the influence of plasma PPL on the activation of the coagulation cascade. ET patients, and particularly those positive for JAK2V617F mutation, display shorter clotting times compared to controls, suggesting higher PPL-dependent procoagulant activity.